204 related articles for article (PubMed ID: 3606838)
21. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
22. [The treatment of atherosclerosis and hypertension using extracorporeal therapy methods].
Malaia LT; Topchiĭ II; Volkov VI; Kondakov IK
Vestn Akad Med Nauk SSSR; 1991; (3):30-5. PubMed ID: 1882537
[TBL] [Abstract][Full Text] [Related]
23. [The use of angiotensin-converting enzyme inhibitors in chronic diffuse kidney diseases].
Kutyrina IM; Tareeva IE; Gerasimenko OI; Rogov VA; Miroshnichenko NG
Ter Arkh; 1995; 67(5):20-3. PubMed ID: 7638769
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal methods in the management of severe and malignant arterial hypertension.
Arabidze GG; Kukharchuk VV; Kutsenko AI; Legkonogov AV; Zaruba AYu
Health Psychol; 1988; 7 Suppl():113-25. PubMed ID: 3243217
[TBL] [Abstract][Full Text] [Related]
25. [The characteristics of the hypotensive effect of combined cryo- and interference therapy in arterial hypertension patients].
Petrova EG; Orekhova EM; Nesterov NI; Lebedeva EV
Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (6):3-5. PubMed ID: 10641537
[TBL] [Abstract][Full Text] [Related]
26. [Changes in blood rheological properties in patients with hypertension].
Shabanov VA; Terekhina EV; Kostrov VA
Ter Arkh; 2001; 73(10):70-3. PubMed ID: 11763523
[TBL] [Abstract][Full Text] [Related]
27. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function].
Wambach G; Godehardt E; Lang R; Haerlin R; Meurer KA
Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693
[TBL] [Abstract][Full Text] [Related]
28. Accelerated (malignant) hypertension: a study of 121 cases between 1974 and 1996.
Scarpelli PT; Livi R; Caselli GM; Di Maria L; Teghini L; Montemurro V; Toti G; Becucci A
J Nephrol; 1997; 10(4):207-15. PubMed ID: 9377729
[TBL] [Abstract][Full Text] [Related]
29. [The hemodynamic, humoral and cellular effects of plasmapheresis in a refractory form of hypertension].
Koval' SN; Kirienko AN; Vasil'ev IuM; Osetskiĭ AI; Babadzhan VD; Shuliak LN; Zeĭnalov FM
Klin Med (Mosk); 1995; 73(1):25-6. PubMed ID: 7791297
[TBL] [Abstract][Full Text] [Related]
30. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
31. [Dynamics of arterial pressure and function of the solitary kidney during remote periods after nephrectomy for malignant arterial hypertension].
Rustamova MT; Spivak GL
Ter Arkh; 1978; 50(4):63-6. PubMed ID: 663846
[No Abstract] [Full Text] [Related]
32. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
33. [A possible mechanism of the hypotensive effect of laser irradiation in patients with ischemic heart disease with arterial hypertension].
Vasil'ev AP; Strel'tsova NN
Vopr Kurortol Fizioter Lech Fiz Kult; 2001; (5):17-20. PubMed ID: 11785330
[TBL] [Abstract][Full Text] [Related]
34. [Effect of captopril on the level of arterial pressure and functional state of the kidney in symptomatic (renal) stable and malignant arterial hypertension].
Lordkipanidze NL; Paleeva FM; Arabidze GG
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):39-41. PubMed ID: 6357226
[TBL] [Abstract][Full Text] [Related]
35. Renal revascularization as treatment for malignant hypertension.
Laroche GP; Lachance JG; Lebel M
Can J Surg; 1980 Jul; 23(4):329-42. PubMed ID: 7417891
[TBL] [Abstract][Full Text] [Related]
36. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
37. [The long-term results on arterial pressure and kidney function after the percutaneous transluminal dilatation of renal artery stenosis].
Rodríguez Pérez JC; Maynar Moliner M; Pérez Borges P; Plaza Toledano C; Reyes Pérez R; Pulido Duque JM; Palop Cubillo L; Rodríguez Pérez A
Med Clin (Barc); 1997 Mar; 108(10):366-72. PubMed ID: 9139142
[TBL] [Abstract][Full Text] [Related]
38. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
Zheng S; Nath V; Coyne DW
Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
[TBL] [Abstract][Full Text] [Related]
39. Relationship between arterial hypertension and renal damage in chronic kidney disease: insights from ABPM.
Paoletti E; Bellino D; Amidone M; Rolla D; Cannella G
J Nephrol; 2006; 19(6):778-82. PubMed ID: 17173252
[TBL] [Abstract][Full Text] [Related]
40. [The effect of the joint use of plasmapheresis and magnetic treatment of the blood on the indices of blood rheology and hemodynamics in hypertension patients].
Alizade IG; Karaeva NT
Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (3):10-2. PubMed ID: 7941464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
